Cargando…

Triggering atrial fibrillation after omalizumab injection in a patient with chronic spontaneous urticarial. A case report

INTRODUCTION: Omalizumab is recommended as a third-line treatment in the treatment of chronic spontaneous urticaria. During omalizumab use, which has high efficacy and safety, the side effects observed are usually moderate and temporary. Here we discuss the triggering of atrial fibrillation followin...

Descripción completa

Detalles Bibliográficos
Autor principal:	Cildag, Songul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Iuliu Hatieganu University of Medicine and Pharmacy 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448490/ https://www.ncbi.nlm.nih.gov/pubmed/30957094 http://dx.doi.org/10.15386/cjmed-1082

Ejemplares similares

The effect of omalizumab treatment on IgE and other immunoglobulin levels in patients with chronic spontaneous urticaria and its association with treatment response
por: Çildağ, Songül, et al.
Publicado: (2018)

Omalizumab for Urticarial Vasculitis: Case Report and Review of the Literature
por: Ghazanfar, Misbah Nasheela, et al.
Publicado: (2015)

Patient-reported outcomes in urticarial vasculitis treated with omalizumab: case report
por: Cherrez-Ojeda, Ivan, et al.
Publicado: (2018)

Normocomplementaemic urticarial vasculitis: effective treatment with omalizumab
por: de Brito, Marianne, et al.
Publicado: (2018)

Real-World Experience on Omalizumab Treatment for Patients with Normocomplementemic Urticarial Vasculitis
por: Liu, Taoming, et al.
Publicado: (2021)

Omalizumab as a Succesfull Therapy in Normocomplementemic Urticarial Vasculitis: A Series of Four Patients and Review of the Literature
por: Degirmentepe, Ece Nur, et al.
Publicado: (2019)

Clinical and laboratory characteristics of chronic spontaneous urticaria with connective tissue diseases: A cross-sectional study
por: Çildağ, Songül, et al.
Publicado: (2021)

The association between chronic spontaneous urticaria and HLA class I and class II antigen
por: DOĞAN, Neslihan, et al.
Publicado: (2020)

Can chronic spontaneous urticarial produce symptoms of neuropathic pain?()
por: Gürel, Gülhan, et al.
Publicado: (2023)

COVID-19 in a patient with hypocomplementemic urticarial syndrome and MPO-ANCA vasculitis on hemodialysis treated with omalizumab()
por: Baldallo, Cinthia, et al.
Publicado: (2021)

Comparison of immunoglobulin E anti-thyroid peroxidase antibodies in patients with Hashimoto thyroiditis and chronic spontaneous urticaria
por: Çildağ, Songül, et al.
Publicado: (2021)

Case Report: Omalizumab for Chronic Spontaneous Urticaria in Pregnancy
por: Liao, Shuang-Lu, et al.
Publicado: (2021)

Case report: Severe chronic spontaneous urticaria successfully treated with omalizumab and dupilumab
por: Puxkandl, Viktoria, et al.
Publicado: (2023)

Elasomeran: Urticarial vasculitis: case report
Publicado: (2022)

SECONDARY URTICARIAL VASCULITIS AND CHRONIC SPONTANEOUS URTICARIA ASSOCIATED WITH COVID-19 VACCINATION
por: Chang, T., et al.
Publicado: (2022)

OMALIZUMAB IN TREATMENT-RESISTANT CHRONIC SPONTANEOUS URTICARIA
por: Godse, Kiran V
Publicado: (2011)

Profile of omalizumab in the treatment of chronic spontaneous urticaria
por: Labrador-Horrillo, Moises, et al.
Publicado: (2015)

AZD-1222: Urticarial vasculitis: case report
Publicado: (2022)

Tozinameran: Neutrophilic urticarial dermatosis: case report
Publicado: (2022)

Development of Demodicosis after Omalizumab Injection
por: Park, Sujin, et al.
Publicado: (2023)

Urticarial Vasculitis in a Teenage Girl
por: McGuffin, Aaron, et al.
Publicado: (2013)

Differential diagnosis between urticarial vasculitis and chronic spontaneous urticaria: An international Delphi survey
por: Krause, Karoline, et al.
Publicado: (2023)

Pneumonia as a trigger for atrial fibrillation
por: Nichols, Larry
Publicado: (2017)

Urticarial rashes following guggulu intake: A case report
por: Rastogi, Sanjeev
Publicado: (2017)

An unusual cause of reactive arthritis with urticarial: A case report
por: Alamlih, Laith, et al.
Publicado: (2020)

Omalizumab's efficacy and safety against chronic spontaneous urticaria
por: Özdemir, Öner
Publicado: (2023)

A novel histopathological scoring system to distinguish urticarial vasculitis from chronic spontaneous urticaria
por: Puhl, Viktoria, et al.
Publicado: (2021)

Chronic urticarial plaques in a young woman
por: Ward, Suzanne C., et al.
Publicado: (2021)

Urticarial vasculitis
por: Gu, Stephanie L., et al.
Publicado: (2021)

Hypocomplementemic urticarial vasculitis syndrome: a look beyond urticarial lesions
por: Pereira, Helena Pires, et al.
Publicado: (2023)

Omalizumab Use in Chronic Spontaneous Urticaria during Pregnancy and a Four Years' Follow-Up: A Case Report
por: Losappio, Laura Michelina, et al.
Publicado: (2020)

Rhupus syndrome and Chiari's network
por: Sargin, Gokhan, et al.
Publicado: (2018)

SARS‐CoV‐2 infection as a potential triggering factor for urticarial vasculitis during pregnancy: A case report
por: Shahidi Dadras, Mohammad, et al.
Publicado: (2021)

Urticarial Vasculitis-Associated Intestinal Ischemia
por: Wong, Uni, et al.
Publicado: (2016)

Normocomplementemic Urticarial Vasculitis: An Unusual Presentation
por: Manappallil, Robin George, et al.
Publicado: (2020)

Ixekizumab‐induced urticarial drug eruption
por: Kaneoka, Ayaka, et al.
Publicado: (2023)

Complete response to dupilumab in a patient with chronic spontaneous urticaria who did not tolerate omalizumab
por: Zhu, Changhua, et al.
Publicado: (2022)

Plasmapheresis in a Patient With "Refractory" Urticarial Vasculitis
por: Kartal, Ozgur, et al.
Publicado: (2012)

Left atrial dissection as a trigger for recurrent atrial fibrillation
por: Kashou, Anthony H., et al.
Publicado: (2020)

Hypocomplementemic Urticarial Vasculitis Syndrome with Membranous Nephropathy: Case Report
por: Jung, Su Woong, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_eskidoq328a587e63ml2i9ni8n